Ligand validation:5EA6

NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5EA6_NHE_F_601	44%	22%	0.234	0.963	1.39	1.86	2	4	0	0	100%	1
6EAI_NHE_B_606	71%	23%	0.142	0.964	1.35	1.81	2	4	0	0	100%	1
6EAN_NHE_F_602	59%	21%	0.172	0.954	1.44	1.89	3	5	0	0	100%	1
5KWW_NHE_F_602	54%	20%	0.205	0.971	1.43	1.96	2	5	0	0	100%	1
6EAM_NHE_F_602	54%	21%	0.2	0.965	1.42	1.87	3	5	0	0	100%	1
5EA4_NHE_F_601	52%	20%	0.205	0.966	1.44	1.93	3	4	0	0	100%	1
5TSP_NHE_A_1001	99%	51%	0.053	0.99	0.93	0.98	-	1	0	0	100%	1
3WXP_NHE_A_404	99%	10%	0.052	0.986	1.81	2.52	4	7	0	0	100%	0.94
2DSY_NHE_C_1001	99%	34%	0.051	0.979	1.49	1.14	1	1	0	0	100%	1
3WH6_NHE_A_505	99%	13%	0.056	0.984	1.25	2.71	2	5	0	0	100%	1
3O1W_NHE_B_488	98%	17%	0.063	0.985	1.36	2.21	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.